FDA Investigator: Omotunde O. Osunsanmi

- Omotunde O. Osunsanmi first started conducting FDA inspections in 2000, with the last inspection in 2022. Over that time, Omotunde O. Osunsanmi has conducted 203 inspections at 132 companies across 145 sites.

Get Omotunde Osunsanmi's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 National Genetics Institute, Los Angeles | 2022

Out-of-stock
Omotunde O. Osunsanmi
Biologic Form 483

FDA 483 Dendreon Pharmaceuticals LLC, Seal Beach | 2019

Out-of-stock
Omotunde O. Osunsanmi
Biologic Form 483

FDA 483 GSK Vaccines S.r.l, Sovicille | 2019

Out-of-stock
Omotunde O. Osunsanmi
Biologic Form 483

FDA 483 GlaxoSmithKline Vaccines Srl, Siena | 2019

Out-of-stock
Omotunde O. Osunsanmi
Biologic Form 483

FDA 483 Hologic Ltd., Livingston | 2019

Out-of-stock
Omotunde O. Osunsanmi
Biologic Form 483

FDA 483 Bayer Healthcare, LLC, Berkeley | 2018

Out-of-stock
Omotunde O. Osunsanmi
Biologic Form 483

FDA 483 MedImmune U.K. Limited, Liverpool | 2018

Out-of-stock
Omotunde O. Osunsanmi
Biologic Form 483

FDA 483 Sanofi Winthrop Industrie, Le Trait | 2018

Out-of-stock
Omotunde O. Osunsanmi
Biologic Form 483

FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC, Sanford | 2018

Out-of-stock
Omotunde O. Osunsanmi
Biologic Form 483

Co-Investigators (77)